Minerco to Launch CB Squeeze from The Herbal Collection™

HOUSTON, May 2, 2016 /PRNewswire/ -- Minerco, Inc. (OTC: MINE) announces its The Herbal Collection™ ("THC") brand has scheduled a commercial scale production run of CB Squeeze. CB Squeeze, sub-branded under the THC brand, in a 1 oz. squeeze pack and enhanced with micellized Cannabidiol (CBD) and natural herbal extracts, is expected to be available for purchase within sixty (60) days.

CB Squeeze contains the highest quality natural herbs combined with a propriety blend of micellized CBD in a squeeze pack ideal for the on-the-go consumer. CB Squeeze has 5 milligrams of micellized high grade CBD (the equivalent of over 25 milligrams of non-micellized CBD) sourced from CBD dominant hemp plants from an established "grass roots" supplier.

The proven micellization technology ensures the highest bio availability and absorption rates of the CBD to the consumer. This state of the art micellization technology combined with the widely accepted health benefits of CBD sourced from hemp, and the ability to sell CB Squeeze in all 50 states and online, is expected to strategically position Minerco's CB Squeeze within the category.

The packaging and flavor portfolio will be available on The Herbal Collection's social media pages at:

www.twitter.com/THCBrands 
www.facebook.com/THC-Brands 
www.instagram.com/THCBrands

"After months, even years, of research, feedback and planning, we will launch The Herbal Collection with the initial product being CB Squeeze. The development of CB Squeeze is complete, and we have scheduled, and paid for, the initial production run. CB Squeeze legally delivers the many benefits of hemp-based CBD to consumers in all 50 states, and its small, lightweight packaging makes it perfect for online consumers," said V. Scott Vanis, Minerco's Chairman and CEO. "The Herbal Collection has also developed CB Teas and CB Shot, but launching CB Squeeze first is the most cost effective test of this collection. Many updates are forthcoming, so please follow us on social media for updates."

About Minerco, Inc.
Minerco, Inc. (OTC:MINE) is an emerging growth company specializing in the food and beverage industry. Its portfolio includes Athena Brands, Inc., The Herbal Collection™ and Coffee Boost™.  Athena Brands, Inc. is a specialty beverage company that develops, produces, markets and distributes a diversified collection of forward-thinking, enhanced and better-for-you consumer brands. The Athena Brands portfolio includes Avanzar Sales & Distribution, LLC, VitaminFIZZ®, Vitamin Creamer® and Island Style™.

www.minerco.com 
www.twitter.com/MinercoInc 
www.facebook.com/MinercoInc

About CBD
Cannabidiol (CBD) is a compound in hemp that has shown to offer beneficial medical effects to the body without the psychoactive effects associated with Tetrahydrocannabinol (THC). Scientific and clinical research, much of it sponsored by the US government, underscores CBD's potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, paranoia and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.

About Micellization 
Micelles are the atom sized stable aggregates of surfactant molecules, which form spontaneously in surfactant solutions. Put simply: Micellization is the scientific process of coating a particle in a surfactant solution to yield a higher potency at delivery.

Public Disclosure
Details of the Company's business, finances and agreements can be found as part of the Company's continuous public disclosure as a fully reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, please visit: www.minerco.com. The above statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease.

Safe Harbor Statement
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations and assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Some of these uncertainties include, without limitation, the company's ability to perform under existing contracts or to procure future contracts. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, successful implementation of our business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. We undertake no obligation and do not intend to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize. Many factors could cause actual results to differ materially from our forward-looking statements.

CONTACT:
Minerco, Inc.
V. Scott Vanis
[email protected]
888-473-5150

SOURCE Minerco, Inc.

Related Links

http://www.minerco.com